Study finds wide county-level variation in rates of surgery for early-stage lung cancer

December 05, 2019

A new study finds more than two-fold differences between counties with the lowest and highest rates of surgery for patients with early stage lung cancer, with socioeconomic and healthcare delivery factors contributing to the gap. The study appears in the journal Chest.

Lung cancer is the leading cause of cancer-related death in the United States, with non-small cell lung cancer (NSCLC) accounting for about 85% of cases. Surgery is the standard treatment for early-stage (I or II) disease, but studies have documented variations in receipt of curative-intent surgery by race, facility type, and geography.

The authors of the current study recently reported substantial state-level variations in receipt of curative-intent surgery for NSCLC in the United States. For the current study, investigators at the American Cancer Society and Baptist Cancer Center, Memphis , led by Helmneh Sineshaw, M.D., MPH, looked at county-level variations within states to gain a sharper picture of the extent of care delivery problems.

A total of 179,189 patients 35 and older diagnosed with stage I/II NSCLC between 2007-2014 in 2,263 counties were identified from 39 states, the District of Columbia, and Detroit population-based cancer registries compiled by the North American Association of Central Cancer Registries. The percentage of patients who underwent surgery was calculated for each county with 20 or more cases of NSCLC.

The authors found surgery rates ranged from 12.8% to 48.6% in the 10% of counties with the lowest surgery rates to 74.3% to 91.7% in the 10% of counties with the highest rates of surgery. Pockets of low surgery rate-counties within each state were also identified. For example, there was a 25% absolute difference between the lowest and highest surgery receipt rate-counties in Massachusetts. Overall, counties in the lowest quartile for receipt of surgery were those with high proportion of non-Hispanic blacks, high poverty and uninsured rate, low surgeon-to-population ratio, and nonmetropolitan status.

"Receipt of curative-intent surgery for early-stage NSCLC varied substantially across counties in the United States with pockets of low receipt counties, even within states with high surgical resection rates," write the authors. "Area-level socioeconomic and healthcare delivery factors partially contributed to these variations, suggesting that concerted policy interventions targeting low access and high poverty counties may reduce variations in receipt of curative-intent surgery."

The authors say further studies are needed to identify and address gaps in access to surgical treatment of early-stage NSCLC, such as more direct evaluation of patient-, provider-, institution-, and community-level factors influencing access to and choice for or against curative-intent treatment modalities.
Article: County-Level Variations in Receipt of Surgery for Early-Stage Non-Small Cell Lung Cancer in the United States; Sineshaw et al.; CHEST 2019 doi: 10.1016/j.chest.2019.09.016

URL upon publication:

American Cancer Society

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to